SCHEMBL7310245

SCHEMBL7310245

Cc1c(CO)ncn1C(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
ALDH1A1 P00352 5/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
HPGD P15428 1/20 0.33
HIF1A Q16665 1/20 0.33
HSD17B10 Q99714 1/20 0.33
KDM4E B2RXH2 1/20 0.33
KMT2A Q03164 3/20 0.32
MEN1 O00255 1/20 0.32
CHRM2 P08172 1/20 0.31
CHRM4 P08173 1/20 0.31
CHRM5 P08912 1/20 0.31
CHRM1 P11229 1/20 0.31
CHRM3 P20309 1/20 0.31
HSP90AA1 P07900 1/20 0.30
FGFR1 P11362 1/20 0.30
SRC P12931 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6743058 0.88 CYP11B1 (0.33) CYP11B1CYP11B2ALDH1A1CYP1A2CYP2D6
SCHEMBL6667217 0.85 CYP11B1 (0.37) CYP11B1CYP11B2ALDH1A1KDM4EHSP90AA1
SCHEMBL846 0.84 CYP11B1 (0.34) CYP11B1CYP11B2L3MBTL1CYP1A2CYP2D6
SCHEMBL9585649 0.84 TAAR1 (0.35) CYP11B1CYP11B2SMN1; SMN2
SCHEMBL6662261 0.84 KDM4E (0.34) CYP11B1CYP11B2KDM4EHSP90AA1
SCHEMBL7274096 0.81 MEN1 (0.37) CYP11B1CYP11B2KDM4EKMT2AMEN1
SCHEMBL9603228 0.81 CYP1A2 (0.37) CYP1A2HIF1AKMT2AMEN1CHRM4
SCHEMBL10457156 0.80 P2RX3 (0.36) CYP11B1CYP11B2ALDH1A1KDM4EKMT2A
SCHEMBL7273914 0.78 ADRA2C (0.35) CYP11B1CYP11B2ALDH1A1CYP2D6KDM4E
SCHEMBL10439558 0.78 CYP1A2 (0.44) CYP11B1CYP11B2ALDH1A1L3MBTL1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0783495-B1 QUINOXALINE DERIVATIVES USEFUL IN THERAPY PFIZER LTD (GB) 2002-02-27 EP disclosed
US-5852016-A Quinoxaline derivatives useful in therapy PFIZER INC. (US) 1998-12-22 US disclosed
EP-0783495-A1 QUINOXALINE DERIVATIVES USEFUL IN THERAPY Pfizer Limited (GB) 1997-07-16 EP disclosed
WO-1996009295-A1 QUINOXALINE DERIVATIVES USEFUL IN THERAPY PFIZER LIMITED (GB) 1996-03-28 WO disclosed
EP-0269599-B1 Substituted 1H-imidazoles UCB SA (BE) 1993-12-15 EP disclosed
US-5202343-A Treating anxiety, psychological disorders GLAXO GROUP LIMITED (GB) 1993-04-13 US disclosed
EP-0242973-B1 INDOLE DERIVATIVES, METHOD FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM GLAXO GROUP LIMITED (GB) 1991-07-17 EP disclosed
EP-0194984-B1 DERIVATIVES OF IMIDAZOLE, THEIR PREPARATION AND UTILISATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE DERIVATIVES CONTINENTAL PHARMA, INC. (BE) 1990-04-04 EP disclosed
US-4859662-A Tetrahydro-imidazolylmethylcarbazolones and analogs thereof for treating 5-HT function disturbances GLAXO GROUP LIMITED (GB) 1989-08-22 US disclosed
US-4822881-A PSYCHOTIC DISORDERS, ANXIETY, NAUSEA, VOMITING GLAXO GROUP LIMITED 1989-04-18 US disclosed
US-4814343-A ANTIISCHEMIC U C B, S.A. (BE) 1989-03-21 US disclosed
US-4808581-A ANXIOLYTIC, ANTIEMETIC, TREATMENT OF PSYCHOLOGICAL DISORDERS GLAXO GROUP LIMITED (GB) 1989-02-28 US disclosed
EP-0269599-A2 Substituted 1H-imidazoles U C B, S.A. (BE) 1988-06-01 EP disclosed
US-4738979-A ADRENERGIC RECEPTORS; ANTI-CONVULSIVE DRUG; TREATMENT OF METABOLIC AND NEUTRAL DISORDERS G. D. SEARLE & CO. (US) 1988-04-19 US disclosed
EP-0242973-A1 Indole derivatives, method for their preparation and pharmaceutical compositions containing them GLAXO GROUP LIMITED (GB) 1987-10-28 EP disclosed
EP-0194984-A1 Derivatives of imidazole, their preparation and utilisation, and pharmaceutical compositions containing these derivatives CONTINENTAL PHARMA, INC. (BE) 1986-09-17 EP disclosed